B.J. Brenninkmeijer

Identification of Patients With Variants in TPMT and Dose Reduction Reduces Hematologic Events During Thiopurine Treatment of Inflammatory Bowel Disease

Marieke J. H. Coenen, Dirk J. de Jong, Corine J. van Marrewijk et al. · Gastroenterology · 2015 · 193 citations · Full text

Inflammation, Autoimmune Disease, Hematology +7

Five methods for determining low-density lipoprotein cholesterol compared.

Pierre N.M. Demacker, Anneke Hijmans, B.J. Brenninkmeijer et al. · Clinical Chemistry · 1984 · 100 citations

Lipid Analysis, Metabolic Syndrome, Cardiovascular Disease +15

Catabolism of chylomicron remnants in normolipidemic subjects in relation to the apoprotein E phenotype

B.J. Brenninkmeijer, P.M.J. Stuyt, Pierre N.M. Demacker et al. · Journal of Lipid Research · 1987 · 94 citations · Full text

The relevance of a protein-enriched low density lipoprotein as a risk for coronary heart disease in relation to other known risk factors

Dorine W. Swinkels, Pierre N.M. Demacker, Jan C.M. Hendriks et al. · Atherosclerosis · 1989 · 38 citations

Metabolic Syndrome, Cardiovascular Epidemiology, Cardiovascular Disease +10

Apolipoprotein E phenotypes, serum lipoproteins and apolipoproteins. in angiographically assessed coronary heart disease

P.M.J. Stuyt, B.J. Brenninkmeijer, Pierre N.M. Demacker et al. · Scandinavian Journal of Clinical and Laboratory Investigation · 1991 · 32 citations

Apoe Phenotype, Hypertension, Hyperlipidemia +19